Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

By Klugman K.P.   Koornhof H.J.   Robbins J.B.   Le Cam N.N.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 435-438

Elsevier

Access to resources Recommend Favorite

Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa

By Wandel G.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1815-1815

Elsevier

Access to resources Recommend Favorite

Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa

By Arya S.C.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 244-244

Elsevier

Access to resources Recommend Favorite

Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi(R))

By Kroon F.P.   van Dissel J.T.   Ravensbergen E.   Nibbering P.H.   van Furth R.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2941-2945

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine-vax-TyVi ( R)-in Cuban school children and teenagers

By Azze R.F.O.   Rodrguez J.C.M.   Iniesta M.G.   Marchena X.R.F.   Alfonso V.M.R.   Padron F.T.S.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2758-2760

Elsevier

Access to resources Recommend Favorite